Polar Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Polar Capital's BMY Position: Q3 2020 in Review
Polar Capital increased its Bristol-Myers Squibb (BMY) stake by 465% in Q3 2020, buying an estimated $62.2M and bringing the position to 1,256,451 shares worth $75.8M. The position accounts for 0.56% of the portfolio, ranked #51.
Polar Capital first reported a position in BMY in Q2 2013 and has held it in 20 quarters since. The position peaked at $91.3M in Q1 2020. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- Polar Capital held 1,256,451 shares of Bristol-Myers Squibb worth $75.8M as of Q3 2020.
- Polar Capital bought 1,034,045 Bristol-Myers Squibb shares in Q3 2020, an estimated $62.2M.
- Bristol-Myers Squibb made up 0.56% of Polar Capital's portfolio in Q3 2020, its #51 holding.
- Polar Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 20 quarters since.
- Polar Capital's Bristol-Myers Squibb position peaked at $91.3M in Q1 2020.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.